FDA approves new treatment for certain advanced or metastatic breast cancers - FDA.gov

Washington Post

FDA approves new treatment for certain advanced or metastatic breast cancers FDA.gov The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has ... FDA Approves Abemaciclib (Verzenio) for Advanced HR+ Breast CancerMedscape Eli Lilly wins US approval for breast cancer drugReuters FDA approves Lilly pill for common advanced breast cancerWashington Post Healio -Pharmacy Times -Monthly Prescribing Reference (registration) -Newburgh Gazette all 31 news articles »

from Health - Google News http://ift.tt/2fDAvGv